| Dr Elizabeth C Washburne, MD | |
|
6524 U S Highway 98, Hattiesburg, MS 39402-8569 | |
| (601) 268-9393 | |
| (601) 268-9559 |
| Full Name | Dr Elizabeth C Washburne |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 6524 U S Highway 98, Hattiesburg, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760455257 | NPI | - | NPPES |
| 00119935 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 14429 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern Women's Health, Pllc | 2567497985 | 38 |
| Womens Pavilion Of South Mississippi Pllc | 5799769535 | 11 |
News Archive
A molecular switch found in the fat tissue of obese mice is a critical factor in the development of insulin resistance, report scientists at the Salk Institute for Biological Studies.
Democrats are likely to again push to give billions in health coverage assistance to Ground Zero workers when they return from their recess, Roll Call reports. "A Democratic leadership aide said Tuesday that the bill likely would get the green light for floor action shortly after the House returns Sept. 14 in conjunction with events planned to commemorate the ninth anniversary of the Sept. 11 terrorist attacks."
Findings from three research studies have shown that around three quarters of cancer patients who suffer from major depression do not receive treatment for their depression and that a newly developed medical programme has proven more effective than standard care at reducing depression in these patients.
An important focus of medical research today is on translating new scientific discoveries into advances in clinical care that will lead to meaningful improvements in health outcomes. Ongoing ethical, legal, and social issues in this era of "translational" research are the subject of a special symposium in the October issue of The American Journal of the Medical Sciences (AJMS), official journal of the Southern Society for Clinical Investigation.
Pfizer Inc. today announced that data from a Phase 2 efficacy and safety study of tasocitinib the company's investigational oral JAK inhibitor, met its primary endpoint of a statistically significant greater proportion of patients achieving at least a 75 percent reduction from baseline in PASI (Psoriasis Area and Severity Index) at week 12 in individuals with chronic moderate to severe plaque psoriasis.
› Verified 3 days ago
| Entity Name | Womens Pavilion Of South Mississippi Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396795571 PECOS PAC ID: 5799769535 Enrollment ID: O20040726001079 |
News Archive
A molecular switch found in the fat tissue of obese mice is a critical factor in the development of insulin resistance, report scientists at the Salk Institute for Biological Studies.
Democrats are likely to again push to give billions in health coverage assistance to Ground Zero workers when they return from their recess, Roll Call reports. "A Democratic leadership aide said Tuesday that the bill likely would get the green light for floor action shortly after the House returns Sept. 14 in conjunction with events planned to commemorate the ninth anniversary of the Sept. 11 terrorist attacks."
Findings from three research studies have shown that around three quarters of cancer patients who suffer from major depression do not receive treatment for their depression and that a newly developed medical programme has proven more effective than standard care at reducing depression in these patients.
An important focus of medical research today is on translating new scientific discoveries into advances in clinical care that will lead to meaningful improvements in health outcomes. Ongoing ethical, legal, and social issues in this era of "translational" research are the subject of a special symposium in the October issue of The American Journal of the Medical Sciences (AJMS), official journal of the Southern Society for Clinical Investigation.
Pfizer Inc. today announced that data from a Phase 2 efficacy and safety study of tasocitinib the company's investigational oral JAK inhibitor, met its primary endpoint of a statistically significant greater proportion of patients achieving at least a 75 percent reduction from baseline in PASI (Psoriasis Area and Severity Index) at week 12 in individuals with chronic moderate to severe plaque psoriasis.
› Verified 3 days ago
| Entity Name | Southern Women's Health, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174744379 PECOS PAC ID: 2567497985 Enrollment ID: O20051004000733 |
News Archive
A molecular switch found in the fat tissue of obese mice is a critical factor in the development of insulin resistance, report scientists at the Salk Institute for Biological Studies.
Democrats are likely to again push to give billions in health coverage assistance to Ground Zero workers when they return from their recess, Roll Call reports. "A Democratic leadership aide said Tuesday that the bill likely would get the green light for floor action shortly after the House returns Sept. 14 in conjunction with events planned to commemorate the ninth anniversary of the Sept. 11 terrorist attacks."
Findings from three research studies have shown that around three quarters of cancer patients who suffer from major depression do not receive treatment for their depression and that a newly developed medical programme has proven more effective than standard care at reducing depression in these patients.
An important focus of medical research today is on translating new scientific discoveries into advances in clinical care that will lead to meaningful improvements in health outcomes. Ongoing ethical, legal, and social issues in this era of "translational" research are the subject of a special symposium in the October issue of The American Journal of the Medical Sciences (AJMS), official journal of the Southern Society for Clinical Investigation.
Pfizer Inc. today announced that data from a Phase 2 efficacy and safety study of tasocitinib the company's investigational oral JAK inhibitor, met its primary endpoint of a statistically significant greater proportion of patients achieving at least a 75 percent reduction from baseline in PASI (Psoriasis Area and Severity Index) at week 12 in individuals with chronic moderate to severe plaque psoriasis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth C Washburne, MD 6524 U S Highway 98, Hattiesburg, MS 39402-8569 Ph: (601) 268-9393 | Dr Elizabeth C Washburne, MD 6524 U S Highway 98, Hattiesburg, MS 39402-8569 Ph: (601) 268-9393 |
News Archive
A molecular switch found in the fat tissue of obese mice is a critical factor in the development of insulin resistance, report scientists at the Salk Institute for Biological Studies.
Democrats are likely to again push to give billions in health coverage assistance to Ground Zero workers when they return from their recess, Roll Call reports. "A Democratic leadership aide said Tuesday that the bill likely would get the green light for floor action shortly after the House returns Sept. 14 in conjunction with events planned to commemorate the ninth anniversary of the Sept. 11 terrorist attacks."
Findings from three research studies have shown that around three quarters of cancer patients who suffer from major depression do not receive treatment for their depression and that a newly developed medical programme has proven more effective than standard care at reducing depression in these patients.
An important focus of medical research today is on translating new scientific discoveries into advances in clinical care that will lead to meaningful improvements in health outcomes. Ongoing ethical, legal, and social issues in this era of "translational" research are the subject of a special symposium in the October issue of The American Journal of the Medical Sciences (AJMS), official journal of the Southern Society for Clinical Investigation.
Pfizer Inc. today announced that data from a Phase 2 efficacy and safety study of tasocitinib the company's investigational oral JAK inhibitor, met its primary endpoint of a statistically significant greater proportion of patients achieving at least a 75 percent reduction from baseline in PASI (Psoriasis Area and Severity Index) at week 12 in individuals with chronic moderate to severe plaque psoriasis.
› Verified 3 days ago
Jeffrey L Hudson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 421 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5640 Fax: 601-261-3507 | |
Dr. Christina Lynn Goodridge, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 421 S 28th Ave Ste 200, Hattiesburg, MS 39401 Phone: 601-268-5640 | |
Dr. William L Pace, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6524 U S Highway 98, Hattiesburg, MS 39402 Phone: 601-268-9393 Fax: 601-268-9559 | |
Kelly R O'neal, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 421 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5640 Fax: 601-261-3507 | |
Dr. Eldred J Wiser, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6524 U S Highway 98, Hattiesburg, MS 39402 Phone: 601-268-9393 Fax: 601-268-9559 | |
Lauren Ayres Bethea, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 421 S 28th Ave, Suite 200, Hattiesburg, MS 39401 Phone: 601-268-5640 Fax: 601-261-3507 | |
Dr. Eugene Linwood Shannon, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 62 Old Airport Rd, Hattiesburg, MS 39401 Phone: 601-544-4550 Fax: 601-582-3373 |